NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. Pipeline Review, H2 2018
Summary
NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. pipeline Target constitutes close to 6 molecules. The latest report NADPH Oxidase 4 Pipeline Review, H2 2018, outlays comprehensive information on the NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type.
NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. NADPH oxidase 4 is an enzyme belonging to NOX family of NADPH oxidases. NADPH Oxidase 4 is localized to nonphagocytic cells where it acts as an oxygen sensor and catalyzes the reduction of molecular oxygen to various reactive oxygen species. So formed ROS have been implicated in numerous biological functions including signal transduction, cell differentiation and tumor cell growth.
The molecules developed by companies in Phase II, Phase I and Preclinical stages are 1, 1 and 4 respectively. Report covers products from therapy areas Cardiovascular, Metabolic Disorders, Oncology, Respiratory, Gastrointestinal, Genito Urinary System And Sex Hormones, Immunology, Toxicology and Undisclosed which include indications Idiopathic Pulmonary Fibrosis, Prostate Cancer, Acute Ischemic Stroke, Atherosclerosis, Chlorine Poisoning, Diabetic Complications, Diabetic Nephropathy, Ischemia Reperfusion Injury, Kidney Fibrosis, Liver Fibrosis, Lung Cancer, Mustard Gas Sulfur Mustard Poisoning, Nerve Gas Poisoning, NonAlcoholic Steatohepatitis NASH, Primary Biliary Cirrhosis, Pulmonary Radiation Toxicity, Systemic Sclerosis Scleroderma, Type 2 Diabetes and Unspecified.
Furthermore, this report also reviews key players involved in NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
The report provides a snapshot of the global therapeutic landscape for NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3.
The report reviews NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities
The report reviews key players involved in NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. targeted therapeutics and enlists all their major and minor projects
The report assesses NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. targeted therapeutics
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3.
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. development landscape
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope